NCT02297048View on ClinicalTrials.gov

Monocentric STUDY, Randomised Double Blinded (Healthy Subjects, or Transversal (Patients With Gitelman Syndrome)

PHASE4CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Gitelman SyndromePotassium Depletion
Interventions
DIETARY_SUPPLEMENT

Potassium depletion

Healthy subjects will be submitted twice at 15-30 day interval, to a low potassium diet (20mmol/day)

Trial Locations (1)

75015

European George Pompidou Hospital, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02297048 - Monocentric STUDY, Randomised Double Blinded (Healthy Subjects, or Transversal (Patients With Gitelman Syndrome) | Biotech Hunter | Biotech Hunter